Company Close Updates

AstraZeneca PLC ADR underperforms Thursday when compared to competitors

Company Logo

Terrence Horan

Referenced Symbols

The AstraZeneca PLC ADR AZN slipped 1.29% to $59.67 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.73% to 14,823.43 and the Dow Jones Industrial Average DJIA rising 1.56% to 34,912.56. AstraZeneca PLC ADR closed $1.67 below its 52-week high ($61.34), which the company reached on October 11th.

The ADR underperformed when compared to some of its competitors Thursday, as AbbVie Inc. ABBV rose 1.57% to $108.91, Amgen Inc. AMGN rose 1.56% to $206.78, and Gilead Sciences Inc. GILD rose 0.77% to $68.15. Trading volume (5.6 M) remained 327,476 below its 50-day average volume of 5.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.